Physiological Levels of Resveratrol Metabolites are Ineffective as Anti-Leukemia Agents Against Jurkat Leukemia Cells

REFERENCES

• Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S, et al.: Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res 24, 2783–2840, 2004.
   PubMed Web of Science ®Google Scholar
• Colin D, Limagne E, Jeanningros S, Jacquel A, Lizard G, et al.: Endocytosis of resveratrol via lipid rafts and activation of downstream signaling pathways in cancer cells. Cancer Prev Res 4, 1095–1106, 2011.
   PubMed Web of Science ®Google Scholar
• Li G, He S, Chang L, Lu H, Zhang H, et al.: GADD45α and annexin A1 are involved in the apoptosis of HL-60 induced by resveratrol. Phytomedicine 18, 704–709, 2011.
   PubMed Web of Science ®Google Scholar
• Kartal M, Saydam G, Sahin F, and Baran Y: Resveratrol triggers apoptosis through ceramide metabolizing genes in human K562 chronic myeloid leukemia cells. Nutr Cancer 63, 637–644, 2011.
   PubMed Web of Science ®Google Scholar
• Gupta SC, Kannappan R, Reuter S, Kim JH, and Aggarwal BB: Chemosensitization of tumors by resveratrol. Ann NY Acad Sci 1215, 150–160, 2011.
   PubMed Web of Science ®Google Scholar
• Brown VA, Patel KR, Viskaduraki M, Crowell JA, Perloff M, et al.: Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis. Cancer Res 70, 9003–9011, 2010.
   PubMed Web of Science ®Google Scholar
• Patel KR, Scott E, Brown VA, Gescher AJ, Steward WP, et al.: Clinical trials of resveratrol. Ann NY Acad Sci 1215, 161–169, 2011.
   PubMed Web of Science ®Google Scholar
• Walle T, Hsieh F, DeLegge MH, Oatis JE, and Walle UK: High absorption but very low bioavailability of oral resveratrol in humans. Drug Metabol Dispos 32, 1377–1382, 2004.
   PubMed Web of Science ®Google Scholar
• Vitrac X, Desmouliere A, Brouillaud B, Krisa S, Deffieux G, et al.: Distribution of [14C]-trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administration. Life Sci 72, 2219–2233, 2003.
   PubMed Web of Science ®Google Scholar
• Wenzel E, Soldo T, Erbersdobler H, and Somoza V: Bioactivity and metabolism of trans-resveratrol orally administered to Wistar rats. Mol Nutr Food Res 49, 482–494, 2005.
   PubMed Web of Science ®Google Scholar
• Crozier A, Jaganath IB, and Clifford MN: Dietary phenolics: chemistry, bioavailability and effects on health. Nat Prod Rep 26, 1001–1043, 2009.
   PubMed Web of Science ®Google Scholar
• van Duynhoven J, Vaughan EE, Jacobs DM, Kemperman RA, van Velzen EJ, et al.: Metabolic fate of polyphenols in the human superorganism. Proc Natl Acad Sci 108(Suppl 1), 4531–4538, 2011.
   PubMed Web of Science ®Google Scholar
• Bode LM, Bunzel D, Huch M, Cho G-S, Ruhland D, et al.: In vivo and in vitro metabolism of trans-resveratrol by human gut microbiota. Am J Clin Nutr 97, 295–309, 2013.
   PubMed Web of Science ®Google Scholar
• Jung CM, Heinze TM, Schnackenberg LK, Mullis LB, Elkins SA, et al.: Interaction of dietary resveratrol with animal-associated bacteria. FEMS Microbiol Lett 297, 266–273, 2009.
   PubMed Web of Science ®Google Scholar
• Azorín-Ortuño M, Yáñez-Gascón MJ, Vallejo F, Pallarés FJ, Larrosa M, et al.: Metabolites and tissue distribution of resveratrol in the pig. Mol Nutr Food Res 55, 1154–1168, 2011.
   PubMed Web of Science ®Google Scholar
• Nicoletti I, Migliorati, G, Pagliacci MC, Grignani F, and Riccardi, C: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Meth, 139, 271–279, 1991.
   PubMed Web of Science ®Google Scholar
• Prior RL, Hoang H, Gu L, Wu X, Bacchiocca M, et al.: Assays for hydrophilic and lipophilic antioxidant capacity (oxygen radical absorbance capacity (ORAC(FL)) of plasma and other biological and food samples. J Agric Food Chem 51, 3273–3279, 2003.
   PubMed Web of Science ®Google Scholar
• Zunino SJ, Storms DH, Newman JW, Pedersen TL, Keen CL, et al.: Dietary resveratrol does not delay engraftment, sensitize to vincristine or inhibit growth of high-risk acute lymphoblastic leukemia cells in NOD/SCID mice. Int J Oncol 41, 2207–2212, 2012.
   PubMed Web of Science ®Google Scholar
• Dörrie J, Gerauer H, Wachter Y, and Zunino SJ. Resveratrol induces extensive apoptosis by depolarizing mitochondrial membranes and activating caspase-9 in acute lymphoblastic leukemia cells. Cancer Res 61, 4731–4739, 2001.
   PubMed Web of Science ®Google Scholar
• Arif W, Xu S, Isailovic D, Geldenhuys WJ, Carroll RT, et al.: Complexes of the outer mitochondrial membrane protein mitoNEET with resveratrol-3-sulfate. Biochem 50, 5806–5811, 2011.
   PubMed Web of Science ®Google Scholar
• Colca JR, McDonald WG, Waldon DJ, Leone JW, Lull JM, et al.: Identification of a novel mitochondrial protein (“mitoNEET”) crosslinked specifically by a thiazolidinedione photoprobe. Am J Physiol Endocrinol Metab 286, E252–E260, 2004.
   PubMed Web of Science ®Google Scholar
• Wiley SE, Murphy AN, Ross SA, van der Geer P, and Dixon JE: MitoNEET is an iron-containing outer mitochondrial membrane protein that regulates oxidative capacity. Proc Natl Acad Sci 104, 5318–5323, 2007.
   PubMed Web of Science ®Google Scholar
• Banerjee S, Bueso-Ramos C, Aggarwal BB: Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-kB, cyclooxygenase 2, and matrix metalloproteinase 9. Cancer Res 62, 4945–4954, 2002.
   PubMed Web of Science ®Google Scholar
• Li ZG, Hong T, Shimada Y, Komoto I, Kawabe A, et al.: Suppression of N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis in F344 rats by resveratrol. Carcinogenesis 23, 1531–1536, 2002.
   PubMed Web of Science ®Google Scholar
• Lee EO, Lee HJ, Hwang HS, Ahn KS, Chae C, et al.: Potent inhibition of Lewis lung cancer growth by heyneanol A from the roots of Vitis amurensis through apoptotic and anti-angiogenic activities. Carcinogenesis 27, 2059–2069, 2006.
   PubMed Web of Science ®Google Scholar
• Liu HS, Pan CE, Yang W, and Liu XM: Antitumor and immunomodulatory activity of resveratrol on experimentally implanted tumor of H22 in Balb/c mice. World J Gastroenterol 9, 1474–1476, 2003.
   PubMed Web of Science ®Google Scholar
• Tessitore L, Davit A, Sarotto I, and Caderni G: Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21(CIP) expression. Carcinogenesis 21, 1619–1622, 2000.
   PubMed Web of Science ®Google Scholar
• Baur JA and Sinclair DA: Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5, 493–506, 2006.
   PubMed Web of Science ®Google Scholar
• Kimura Y, Okuda H: Resveratrol isolated from Polygonum cuspidatum root prevents tumor growth and metastasis to lung and tumor-induced neovascularization in Lewis lung carcinoma-bearing mice. J Nutr 131, 1844–1849, 2001.
   PubMed Web of Science ®Google Scholar
• Busquets S, Ametller E, Fuster G, Olivan M, Raab V, et al.: Resveratrol, a natural diphenol, reduces metastatic growth in an experimental cancer model. Cancer Lett 245, 144–148, 2007.
   PubMed Web of Science ®Google Scholar
• Weng YL, Liao HF, Li AF, Chang JC, and Chiou RY: Oral administration of resveratrol in suppression of pulmonary metastasis of BALB/c mice challenged with CT26 colorectal adenocarcinoma cells. Mol Nutr Food Res 54, 259–267, 2010.
   PubMed Web of Science ®Google Scholar
• Juan ME, Alfaras I, and Planas JM: Colorectal cancer chemoprevention by trans-resveratrol. Pharmacol Res 65, 584–591, 2012.
   PubMed Web of Science ®Google Scholar
• Huderson AC, Myers JN, Niaz MS, Washington MK, and Ramesh A: Chemoprevention of benzo(a)pyrene-induced colon polyps in ApcMin mice by resveratrol. J Nutr Biochem 24, 713–724, 2013.
   PubMed Web of Science ®Google Scholar
• Patel KR, Brown VA, Jones DJL, Britton RG, Hemingway D, et al.: Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. Cancer Res 70, 7392–7399, 2010.
   PubMed Web of Science ®Google Scholar
• Polycarpou E, Meira LB, Carrington S, Tyrrell E, Modjtahedi H, et al.: Resveratrol 3-O-D-glucuronide and resveratrol 4’-O-D-glucuronide inhibit colon cancer cell growth: evidence for a role of A3 adenosine receptors, cyclin D1 depletion, and G1 cell cycle arrest. Mol Nutr Food Res 57, 1708–1717, 2013.
   PubMed Web of Science ®Google Scholar
• Rotches-Ribalta M, Andres-Lacueva C, Estruch R, Escribano E, and Urpi-Sarda M: Pharmacokinetics of resveratrol metabolic profile in healthy humans after moderate consumption of red wine and grape extract tablets. Pharmacol Res 66, 375–382, 2012.
   PubMed Web of Science ®Google Scholar
• Radko Y, Christensen KB, and Christensen LP: Semi-preparative isolation of dihydroresveratrol-3-O-β-D-glucuronide and four resveratrol conjugates from human urine after oral intake of a resveratrol-containing dietary supplement. J Chromatogr B Analyt Technol Biomed Life Sci 930, 54–61, 2013.
   PubMed Web of Science ®Google Scholar
• Rothces-Ribalta M, Urpi-Sarda M, Martí MM, Reglero G, and Andres-Lacueva C: Resveratrol metabolic fingerprinting after acute and chronic intakes of a functional beverage in humans. Electrophoresis 2013. doi:10.1002/elps.201300262 [Epub ahead of print]
   Web of Science ®Google Scholar
• Augustin MA, Sanguansri L, and Lockett T: Nano- and micro-encapsulated systems for enhancing the delivery of resveratrol. Ann N Y Acad Sci 1290, 107–112, 2013.
   PubMed Web of Science ®Google Scholar
• Wang S, Su R, Nie S, Sun M, Zhang J, Wu D, and Moustaid-Moussa N: Application of nanotechnology in improving bioavailability and bioactivity of diet-derived phytochemicals. J Nutr Biochem 25, 363–376, 2014.
   PubMed Web of Science ®Google Scholar